A newly published study supports the idea that cannabis may help some people in their goal of alcohol cessation.
Despite the fact that legal cannabis is shaping the nation, one senator in Idaho is still trying to push back against possible legalization in his state by proposing a constitutional ban at the state level on psychoactive drugs.
The amendment, proposed by Senator C. Scott Grow, a Republican based in Eagle, would officially amend the constitution, making it more difficult for advocates to legalize at the state level.
This amendment would ban “the production, manufacture, transportation, sale, delivery, dispensing, distribution, possession, or use of a psychoactive drug.” The only exceptions would be drugs approved by the Food and Drug Administration.
Grow is adamant about why he did this—to prevent what he sees as the “erosion” of Idaho drug laws. He worries that if his state follows the lead of other, legal states in the nation, things would change for the worse. He is backed by other conservative senators, including Senate President Pro-Tem Chuck Winder.
“Neighboring states have legalized controlled substances to the detriment of their children, families and communities,” Grow said.
While state-level legalization initially took place in historically blue states like Colorado and California, more conservative states like Montana and Arizona have recently followed suit and legalized. Even South
Because this is the beginning of the year, and because I have had many clients ask me about the status of Washington’s cannabis market lately, I wanted to weigh in on my predictions for Washington cannabis developments in 2021.
Even though we would consider Washington’s marijuana market quite mature when compared to many other states, the Washington State Liquor and Cannabis Board (WSLCB) remains vigilant (and in some cases, militant!) and continues to seek input from stakeholders as it refines its policies and procedures. In early January, the WSLCB adopted a slew of rules that will impact licensees in 2021:
a. Emergency Rules (WAC 314-55-1055) – Marijuana Product Disclosure Form (Effective January 6, 2021)
This rule requires all manufacturers of THC products to disclose all compounds used in production and processing and is specifically targeted to root out any noncompliance with the Vitamin E Acetate Ban (see below).
b. Emergency Rules (WAC 314-55-1065) – LCB Vitamin E Acetate Prohibition (formerly LCB Vitamin E Acetate Ban) (Effective January 6, 2021)
This rule extends the ban on vitamin E acetate.
c. Emergency Rules (WAC 314-55-077) – Marijuana Processor License – Privileges, Requirements and
Editors note: as this story develops, we will update throughout the day with the most recent information.
In addition to the predictable recipients of Donald Trump’s clemency powers—war criminals, corrupt political allies, racketeers, and gun law violators like Lil Wayne—a handful of non-violent pot and drug-related prisoners are also benefiting, thanks to criminal justice advocates and persistent supporters within the cannabis and entertainment community.
Michael “Harry-O” Harris
Harris, known as Harry-O, spent thirty-three years in prison on attempted murder and drug trafficking-related charges. Among other activities, many of which were undertaken inside prison walls, Harry-O co-founded Death Row Records, which he named after a stint on death row in San Quentin.
The now defunct but once extremely influential label played a key role in hip-hop history and helped launch the careers of such greats as Dr Dre, 2Pac and Snoop Dogg.
Snoop has been close to Harry-O ever since.
“Snoop Dogg personally asked me to push for Harry-O’s release. He also sent some heartfelt messages himself to the White House,” said Weldon Angelos, founder and director of Mission [Green]: The Weldon Project.
“Now that it’s happening, he can’t believe it’s real. Snoop owes his career to Harry O,” Angelos told
A Michigan dispensary has come up with an incredibly creative idea to get people on board with the concept of vaccination: offer free cannabis to those willing to get the vaccine.
Calling their promotion “Pot for Shots,” Greenhouse of Walled Lake in Michigan is determined to help up the vaccination rate and get us closer to herd immunity with this special deal. As long as you bring written proof into the store showing that you received your vaccination, you’re eligible for a free, pre-rolled joint in return for your efforts.
“Our goal is to raise awareness of the importance of getting the COVID-19 vaccination as we as a community battle this horrible pandemic,” owner Jerry Millen claims in the official press release put out by Greenhouse of Walled Lake. “‘Pot for Shots’ is our way of showing our commitment in assisting the community [in getting] back to normalcy. We support the safe and responsible use of cannabis and hope this is the beginning of the end of this insidious pandemic.”
While this is a fun way to get more business in the door thanks to the promise of a free preroll, which just about everyone can get behind, there is
It is thought that CBD can work to combat inflammation throughout the body.
Like many chronic lifestyle-related diseases, inflammation is at the core. Obesity may be no different.
When it comes to obesity, doctors oftentimes prescribe medications to treat the accompanying co-morbidities, such as high blood pressure, elevated cholesterol and dysregulated blood glucose. Some note, however, that inflammation is at the root of high blood pressure, high cholesterol and high blood sugar.
– Read the entire article at The Fresh Toast.
France has some of the harshest cannabis laws in Europe–it has been illegal in the country since 1970, the state doesn’t allow medicinal use, and there is no distinction in law between personal use and trafficking, as there is in some countries.
However, France has the highest reported use of cannabis in Europe. Between 2015 and 2017, according to Statista, just over 11% of the French population said they had used cannabis over the previous year, the highest of any European country. The use of cannabis in France dates back to Napoleon’s Egyptian Campaign of 1798 when due to a lack of alcohol, his troops turned to cannabis instead. Even though Napoleon banned the drug, cannabis became more and more popular.
The issue of legalizing cannabis is coming back to the fore in France, as a new survey conducted by Le Parisien, polled French mayors across Paris and found that–even in Republican quarters–50% of Paris’ leaders said they favoured the decriminalization of the drug (only 22% were against, whilst 28% said they needed more information). Research experts told the newspaper that this was also in line with public opinion according to recent surveys.
– Read the entire article at Forbes.
Adult-use cannabis in California has brought quite a few changes to the state, including easier access to needed medicine and a thriving cannabis tourism scene. However, there has been no marked increase in young adult cannabis use since the start of legalization.
The recently published study, which was published in the Addictive Behavior journal and conducted by the University of California at San Diego, looked at cannabis use within a group of 563 young adults, all ages 18 to 24. All the adults resided in California in the years just prior to cannabis legalization, and the trends were monitored based on their activity throughout the study.
Initially, the study was conducted because of concern over cannabis use in teens and young adults. In their abstract, the researchers wrote that teen use is a concern because of the chronic health risks associated with using cannabis, as well as worry over an increase in using tobacco and nicotine products due to legalization.
They took this on because no other studies had looked at this connection before theirs, and to see if cannabis use frequency would increase with recreational sales. They also assumed that more cannabis legalization would lead to more consumption of cannabis
CANNABIS CULTURE – Dr. John Streicher of the University of Arizona says the DEA’s new regulations offer no help to researchers — and he’s not the only one.
“From my point of view it makes no difference at all,” Streicher says under the new rules he will still need to file for a Schedule I license with the DEA, as he did under the old regulations.
Streicher’s research focuses on pain management, often with opioids and requires a Schedule II license. With routine inspections, Streicher can research opioids: codeine, morphine, and oxycodone with little oversight.
The security requirements for storing Schedule I substances in the lab is far higher. Streicher says that isn’t the only difficulty, “It’s the additional burden of all the details.”
Researchers need to provide exact plans in their application for everything they want to do. “A lot of things change in research,” he says. “You make one discovery and that may lead to five new directions that you want to go in.” Streicher says de-scheduling cannabis is the only route to help research.
Dr. Josh Kaplan of Western Washington University says his research focuses on CBD because of the restrictions on THC. “There are companies right
Last Friday, January 15th, the U.S. Department of Agriculture (the “USDA”) announced today’s publication of its hemp production final rule in the Federal Register, which will go into effect on March 22, 2021. This final rule builds on the interim final rule (the “IFR”) that was published on October 31, 2019. It includes revisions based on three public comment periods (you can read more on this issue here and here) but also takes into account “lessons learned from the 2020 growing season.”
These new hemp regulations contain six key provisions, which include:
Licensing requirements; Recordkeeping requirements; Procedures for testing the THC level concentration in the hemp plant; Procedures for disposing of non-compliant hemp (i.e., hemp that exceeds acceptable THC threshold); Compliance provisions; and Procedures for handling violations.
The most significant revisions made to the IFR pertain to the procedures for testing the THC concentration and those for disposing of non-compliant hemp. Below are the highlights.
1. Time of sample collection
The USDA agreed with the concerns expressed by commenters regarding the burden of imposing harvest within 15 days of sampling. As a result, the federal agency extended the window within which hemp must be harvest to 30 days following